Drugs / HMB (Calcium beta-hydroxy-beta-methylbutyrate)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02043171 Comparator | Aug 2014 → Feb 2019 | muscular atrophy | Metabolic Technologies Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HMB (Calcium beta-hydroxy-beta-methylbutyrate) | “HMB (Calcium beta-hydroxy-beta-methylbutyrate)” NCT02043171 ↗ |
| Known as | HMB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02043171 ↗ |